Cargando…

The Value of Serum Cell-Free DNA Levels in Patients With Schizophrenia

Background: Schizophrenia is a severe mental disorder, which has a major impact on the quality of life and imposes a huge burden on the family. However, the pathogenesis of schizophrenia remains unclear and there are no specific biomarkers. Therefore, we intend to explore whether cf-DNA levels are r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Ling-yun, Qi, Jing, Xu, Hong-lei, Lin, Xiang-yun, Sun, Ya-jun, Ju, Shao-qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042127/ https://www.ncbi.nlm.nih.gov/pubmed/33859582 http://dx.doi.org/10.3389/fpsyt.2021.637789

Ejemplares similares

Analytical Value of Cell-Free DNA Based on Alu in Psychiatric Disorders
por: Qi, Jing, et al.
Publicado: (2020)

Reduced Cell-Free Mitochondrial DNA Levels Were Induced by Antipsychotics Treatment in First-Episode Patients With Schizophrenia
por: Ouyang, Houxian, et al.
Publicado: (2021)

BDNF Serum Levels are Associated With White Matter Microstructure in Schizophrenia - A Pilot Study
por: Hammans, Christine, et al.
Publicado: (2020)

Impairment of Executive Functions Associated With Lower D-Serine Serum Levels in Patients With Schizophrenia
por: Hons, Jaromir, et al.
Publicado: (2021)

Relationship Between Curative Effect and Serum Inflammatory Factors Level in Male Patients With First-Episode Schizophrenia Treated With Olanzapine
por: Ma, Jun, et al.
Publicado: (2021)

Effects of varenicline on the serum levels of olanzapine in male patients with Schizophrenia: a randomized controlled trial
por: Deng, Mengling, et al.
Publicado: (2023)

Altered Heart Rate Variability in Patients With Schizophrenia During an Autonomic Nervous Test
por: Liu, Ya, et al.
Publicado: (2021)

Nerve Growth Factor Serum Levels Are Associated With Regional Gray Matter Volume Differences in Schizophrenia Patients
por: Neugebauer, Kristina, et al.
Publicado: (2019)

Reduced Serum Levels of Soluble Interleukin-15 Receptor α in Schizophrenia and Its Relationship to the Excited Phenotype
por: He, Yi, et al.
Publicado: (2022)

Histogenous Hypoxia and Acid Retention in Schizophrenia: Changes in Venous Blood Gas Analysis and SOD in Acute and Stable Schizophrenia Patients
por: Huang, Xingbing, et al.
Publicado: (2021)

Association Between Depressive Symptoms and Serum Brain-Derived Neurotrophic Factor Levels in Patients With First-Episode and Drug-Naïve Schizophrenia
por: Wu, Yuxuan, et al.
Publicado: (2022)

Elevated Osteopontin and Interferon Gamma Serum Levels and Increased Neutrophil-to-Lymphocyte Ratio Are Associated With the Severity of Symptoms in Schizophrenia
por: Kovács, Márton Áron, et al.
Publicado: (2020)

Corrigendum: Nerve Growth Factor Serum Levels Are Associated With Regional Gray Matter Volume Differences in Schizophrenia Patients
por: Neugebauer, Kristina, et al.
Publicado: (2019)

Deficits of Tactile Passive Perception Acuity in Patients With Schizophrenia
por: Liu, Dan, et al.
Publicado: (2020)

Dysbindin-1, BDNF, and GABAergic Transmission in Schizophrenia
por: Jun, Rachel, et al.
Publicado: (2022)

Decreased Peripheral BDNF Levels and Cognitive Impairment in Late-Life Schizophrenia
por: Huo, Lijuan, et al.
Publicado: (2021)

Association Between Serum Insulin-Like Growth Factor 1 Levels and the Clinical Symptoms of Chronic Schizophrenia: Preliminary Findings
por: Okamoto, Naomichi, et al.
Publicado: (2021)

Relationship Between Plasma Olanzapine and N-Desmethyl-Olanzapine Concentration and Metabolic Parameters in Patients With Schizophrenia
por: An, Huimei, et al.
Publicado: (2022)

Associations of decreased serum total protein, albumin, and globulin with depressive severity of schizophrenia
por: Yin, Xu Yuan, et al.
Publicado: (2022)

A Metabolomics Study of Serum in Hospitalized Patients With Chronic Schizophrenia
por: Okamoto, Naomichi, et al.
Publicado: (2021)

Fibroblast Growth Factor 9 as a Potential Biomarker for Schizophrenia
por: Li, Xiao-Ling, et al.
Publicado: (2022)

Comparisons of Serum Interleukin-8 Levels in Major Depressive Patients With Drug-Free Versus SSRIs Versus Healthy Controls
por: Zhu, Zhen Hua, et al.
Publicado: (2022)

Decreased Serum Oxytocin and Increased Homocysteine in First-Episode Schizophrenia Patients
por: Liu, Yong, et al.
Publicado: (2019)

Longitudinal Associations Between Serum Cytokine Levels and Dementia
por: Kim, Ju-Wan, et al.
Publicado: (2018)

Serum NLRP3 Inflammasome and BDNF: Potential Biomarkers Differentiating Reactive and Endogenous Depression
por: Yang, Xin-Jing, et al.
Publicado: (2022)

Small Saccades and Image Complexity during Free Viewing of Natural Images in Schizophrenia
por: Egaña, Jose Ignacio, et al.
Publicado: (2013)

Volumetric Abnormalities in Violent Schizophrenia Patients on the General Psychiatric Ward
por: Liu, FengJu, et al.
Publicado: (2020)

Case report: Recovery of hallucinations and cognitive impairment after administration of donepezil in a patient with schizophrenia and carbon monoxide poisoning
por: Baek, Seon-Hwa, et al.
Publicado: (2022)

Vitamin D Levels in Different Severity Groups of Schizophrenia
por: Akinlade, Kehinde Sola, et al.
Publicado: (2017)

Decreased Plasma Levels of Growth Differentiation Factor 11 in Patients With Schizophrenia: Correlation With Psychopathology and Cognition
por: Yang, Zhao-xi, et al.
Publicado: (2020)

Insulin Resistance and Oxidative Stress: In Relation to Cognitive Function and Psychopathology in Drug-Naïve, First-Episode Drug-Free Schizophrenia
por: Tao, Qi, et al.
Publicado: (2020)

Serum Levels of Vitamin A and Vitamin D and Their Association With Symptoms in Children With Attention Deficit Hyperactivity Disorder
por: Li, Hong-Hua, et al.
Publicado: (2020)

Serum metabolic signatures of schizophrenia patients complicated with hepatitis B virus infection: A (1)H NMR-based metabolomics study
por: Lin, Caigui, et al.
Publicado: (2022)

Human Aquaporin 4 Gene Polymorphisms and Haplotypes Are Associated With Serum S100B Level and Negative Symptoms of Schizophrenia in a Southern Chinese Han Population
por: Wu, Yung-Fu, et al.
Publicado: (2018)

Blood Levels of Glutamate and Glutamine in Recent Onset and Chronic Schizophrenia
por: Madeira, Caroline, et al.
Publicado: (2018)

Bidirectional connectivity alterations in schizophrenia: a multivariate, machine-learning approach
por: Kim, Minhoe, et al.
Publicado: (2023)

The Gut Microbiome and Schizophrenia: The Current State of the Field and Clinical Applications
por: Szeligowski, Tomasz, et al.
Publicado: (2020)

No Impact of Omega-3 Fatty Acid Supplementation on Symptoms or Hostility Among Patients With Schizophrenia
por: Qiao, Yi, et al.
Publicado: (2020)

Association of higher plasma leptin levels with HOMA-IR index, high sensitivity C-reactive protein and glycolipid metabolism in patients with chronic schizophrenia: A multi-center cross-sectional study
por: Liu, Zhiwei, et al.
Publicado: (2022)

Characteristics of Facial Muscle Activity Intensity in Patients With Schizophrenia and Its Relationship to Negative Symptoms
por: Du, Xia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rup9q3h2n20t6d0absabgqa4e5